As a result of COVID-19, elective procedure shutdowns in early Q220 blasted away at revenue results for the US Total Joints Market. When the dust settled, the US Market for Hips and Knees was down -41.9% according to SmartTRAK Financial Dashboard. US Knees experienced the biggest hit due to its exposure from a higher percentage of elective procedures compared to Hips. US Hips did not come through unscathed but suffered less damage.
Among the many topics covered in the comprehensive Q220 Total Joints Market Recap* are:
- Complete Market Overview
- Q220 Knee Overview with Company Revenues and Share
- Q220 Hip Overview with Company Revenues and Share
- Regulatory Highlights
The timing of full market recovery remains uncertain, but by the end of the quarter, US Total Joints showed signs of improvement. Shortly after the close of Q2, Wells Fargo (WFS) reported US insurance claims data showed joint replacement procedures recovering faster than other elective procedures. WFS’ estimated that for the week ending July 10 US Hip and Knee procedures had reached ...